Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

International Business Machines CorpTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? International Business Machines Corp trades at $226.5 (market cap $214.69B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B). The key difference: International Business Machines Corp is far larger — about 53.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.97% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

IBMINDV
Market Cap
$214.69B$4.03B
Volume
4,038,6372,781,171
Sector
TechnologyHealth
52-Week High
$329.23$41.83
52-Week Low
$205.77$24.09
Typical Hold Time
89 Days0 Days
Enterprise Value
$271.83B$4.32B
Dividend Yield
2.97%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM stock trades at $230.78, up 1.66% with recent momentum driven by positive consulting sector sentiment and the launch of self-hosted deployment for its Bob AI platform. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, though technical indicators signal bearish pressure. Recent earnings performance has been mixed with Q2 2026 missing expectations, while analyst consensus remains positive with a $255.50 price target.

IBM presents a balanced investment case with solid profitability metrics (15.52% net margin, 34.62% ROE) and growing AI consulting business ($5.5B book), but faces risks from cyclical mainframe weakness and competitive pressures. The stock trades at reasonable valuations (P/E 20.5) with upside potential if AI initiatives drive sustained growth.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBM
13% Buy87% Sell
Avg holding period · 89 Days
INDV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →